Annual EBITDA
$1.16B$345.90M+42.30%
Summary
- Current Value
- As of today, DXCM annual EBITDA is $1.16B, up +42.30% on
- Historical Performance
- DXCM annual EBITDA is up +112.69% over the past 3 years, up +217.40% over the past 5 years
- All-Time High Comparison
- DXCM annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- DXCM annual EBITDA is +112.69% above its 3-year low of $547.10M reached on an earlier date
- Sector Comparison
- DXCM annual EBITDA is higher than 94.01% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.16B | +42.3% | +112.7% | +217.4% | +2815.3% | |
| Quarterly EBITDA | $388.20M | +57.4% | +140.1% | +212.1% | +4335.7% | |
| TTM EBITDA | $1.16B | +42.3% | +112.7% | +217.4% | +2815.3% | |
| Price | $74.38 | -15.3% | -32.7% | -25.2% | +1919.8% | |
| PE Ratio | 35.54 | -42.3% | -73.7% | -56.9% | – | |
| Annual Revenue | $4.66B | +15.6% | +60.2% | +142.0% | +9486.5% | |
| Annual EPS | $2.09 | +46.7% | +161.8% | +65.1% | +961.6% | |
| $911.80M | +52.0% | +133.1% | +204.4% | +2113.3% | ||
| Annual Net Income | $836.30M | +45.1% | +145.1% | +69.4% | +1615.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.16B | at high | |
| 5Y | $1.16B | at high | |
| All | $1.16B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $547.10M | N/A | +112.7% |
| 5Y | $366.60M | N/A | +217.4% |
| All | -$151.80M | +866.5% |
EBITDA History
FAQ
What is the current annual EBITDA of DXCM?
As of today, DXCM annual EBITDA is $1.16B
What is 1-year change in DXCM annual EBITDA?
DXCM annual EBITDA is up +42.30% year-over-year
What is 3-year change in DXCM annual EBITDA?
DXCM annual EBITDA is up +112.69% over the past 3 years
How far is DXCM annual EBITDA from its all-time high?
DXCM annual EBITDA is currently at its all-time high
How does DXCM annual EBITDA rank versus sector peers?
DXCM annual EBITDA is higher than 94.01% of companies in Healthcare sector
When is DXCM next annual earnings release?
As of today, the next annual earnings release for DXCM has not been scheduled
Quarterly EBITDA
$388.20M$82.10M+26.82%
Summary
- Current Value
- As of today, DXCM quarterly EBITDA is $388.20M, up +26.82% on
- Historical Performance
- DXCM quarterly EBITDA is up +57.36% year-over-year, up +140.07% over the past 3 years
- All-Time High Comparison
- DXCM quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- DXCM quarterly EBITDA is +337.16% above its 3-year low of $88.80M reached on
- Sector Comparison
- DXCM quarterly EBITDA is higher than 94.60% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $388.20M | +26.8% | +57.4% | +140.1% | +212.1% | |
| Annual EBITDA | $1.16B | – | +42.3% | +112.7% | +217.4% | |
| TTM EBITDA | $1.16B | +13.8% | +42.3% | +112.7% | +217.4% | |
| Price | $74.38 | +18.9% | -15.3% | -32.7% | -25.2% | |
| PE Ratio | 35.54 | +2.1% | -42.3% | -73.7% | -56.9% | |
| Quarterly Revenue | $1.26B | +4.2% | +13.1% | +54.5% | +121.4% | |
| Quarterly EPS | $0.68 | -3.9% | +78.0% | +213.7% | -20.6% | |
| $323.00M | +33.2% | +71.0% | +157.6% | +210.6% | ||
| Quarterly Net Income | $267.30M | -5.8% | +76.2% | +191.2% | -24.8% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $388.20M | at high | |
| 3Y | $388.20M | at high | |
| 5Y | $388.20M | at high | |
| All | $388.20M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $193.70M | +100.4% | |
| 3Y | $88.80M | +337.2% | |
| 5Y | $32.70M | +1087.2% | |
| All | -$156.00M | +348.9% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of DXCM?
As of today, DXCM quarterly EBITDA is $388.20M
What is DXCM quarterly EBITDA most recent change?
DXCM quarterly EBITDA was up +26.82% on December 31, 2025
What is 1-year change in DXCM quarterly EBITDA?
DXCM quarterly EBITDA is up +57.36% year-over-year
How far is DXCM quarterly EBITDA from its all-time high?
DXCM quarterly EBITDA is currently at its all-time high
How does DXCM quarterly EBITDA rank versus sector peers?
DXCM quarterly EBITDA is higher than 94.60% of companies in Healthcare sector
When is DXCM next earnings release?
The next earnings release for DXCM is on
TTM EBITDA
$1.16B$141.50M+13.84%
Summary
- Current Value
- As of today, DXCM TTM EBITDA is $1.16B, up +13.84% on
- Historical Performance
- DXCM TTM EBITDA is up +42.30% year-over-year, up +112.69% over the past 3 years
- All-Time High Comparison
- DXCM TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- DXCM TTM EBITDA is +112.69% above its 3-year low of $547.10M reached on an earlier date
- Sector Comparison
- DXCM TTM EBITDA is higher than 93.96% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.16B | +13.8% | +42.3% | +112.7% | +217.4% | |
| Annual EBITDA | $1.16B | – | +42.3% | +112.7% | +217.4% | |
| Quarterly EBITDA | $388.20M | +26.8% | +57.4% | +140.1% | +212.1% | |
| Price | $74.38 | +18.9% | -15.3% | -32.7% | -25.2% | |
| PE Ratio | 35.54 | +2.1% | -42.3% | -73.7% | -56.9% | |
| TTM Revenue | $4.66B | +3.2% | +15.6% | +60.2% | +142.0% | |
| TTM EPS | $2.09 | +16.5% | +46.9% | +156.0% | +73.7% | |
| $911.80M | +17.2% | +52.0% | +133.1% | +204.4% | ||
| TTM Net Income | $836.30M | +16.0% | +45.1% | +145.1% | +69.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.16B | at high | |
| 3Y | $1.16B | at high | |
| 5Y | $1.16B | at high | |
| All | $1.16B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $817.70M | N/A | +42.3% |
| 3Y | $547.10M | N/A | +112.7% |
| 5Y | $366.60M | N/A | +217.4% |
| All | -$157.20M | +840.2% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of DXCM?
As of today, DXCM TTM EBITDA is $1.16B
What is DXCM TTM EBITDA most recent change?
DXCM TTM EBITDA was up +13.84% on December 31, 2025
What is 1-year change in DXCM TTM EBITDA?
DXCM TTM EBITDA is up +42.30% year-over-year
How far is DXCM TTM EBITDA from its all-time high?
DXCM TTM EBITDA is currently at its all-time high
How does DXCM TTM EBITDA rank versus sector peers?
DXCM TTM EBITDA is higher than 93.96% of companies in Healthcare sector
When is DXCM next earnings release?
The next earnings release for DXCM is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- DXCM Official Website www.dexcom.com/global
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1093557/000109355726000027/0001093557-26-000027-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1093557/000109355726000027/0001093557-26-000027-index.htm
- DXCM Profile on Yahoo Finance finance.yahoo.com/quote/DXCM
- DXCM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dxcm